InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Kuhn Thomas, Chief Executive Officer. Officer active across 1 company, notably POXEL. Cumulatively, 5 disclosures have been published. Breakdown: 2 buys · 0 sell. Activity tracked since 24 August 2022. The latest transaction was disclosed on 29 January 2024 (Acquisition). Regulator: AMF. All data is accessible without signup.
Declarations5 total
80,000 shares0ActionEuronext Paris2024DD948921
Ideal exit: 25 Oct 2024 (T+270)
150,000 shares0ActionEuronext Paris2023DD894028
80,000 shares0ActionEuronext Paris2023DD882619
Ideal exit: 24 Oct 2023 (T+270)
400,000 shares0ActionHors plateforme de négociation2022DD877946
150,000 shares0ActionHors plateforme de négociation2022DD858234
5 of 5 declarations
About Kuhn Thomas
Kuhn Thomas is the Chief Executive Officer of Poxel. He leads the company, which specializes in developing treatments for metabolic diseases. His role is crucial for the strategy and growth of Poxel in the pharmaceutical market.
